NeoGenomics Inc (NEO)

NASDAQ
Currency in USD
Disclaimer
13.44
-0.34(-2.47%)
Closed
After Hours
13.50+0.06(+0.45%)
NEO Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
13.4114.05
52 wk Range
11.9721.22
Prev. Close
13.78
Open
13.93
Day's Range
13.41-14.05
52 wk Range
11.97-21.22
Volume
634,388
Average Volume (3m)
770,355
1-Year Change
12.37%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
NEO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
21.18
Upside
+57.59%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings upwards for the upcoming period
Show more

NeoGenomics Inc Company Profile

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients’ oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Compare NEO to Peers and Sector

Metrics to compare
NEO
Peers
Sector
Relationship
P/E Ratio
−21.9x−2.3x−0.6x
PEG Ratio
−0.70−0.150.00
Price/Book
1.9x2.7x2.6x
Price / LTM Sales
2.7x1.5x3.3x
Upside (Analyst Target)
45.1%26.7%44.5%
Fair Value Upside
Unlock4.8%6.0%Unlock

People Also Watch

54.13
HALO
+0.52%
6.44
ARRY
-0.31%
69.43
DXCM
+1.18%
45.78
CORT
+2.51%
20.7200
ADMA
+2.68%

FAQ

What Is the NeoGenomics (NEO) Stock Price Today?

The NeoGenomics (NEO) stock price today is 13.44. Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does NeoGenomics Trade On?

NeoGenomics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for NeoGenomics?

The stock symbol for NeoGenomics is "NEO."

What Is the NeoGenomics Market Cap?

As of today, NeoGenomics market cap is 1.72B.

What is NeoGenomics Earnings Per Share?

The NeoGenomics EPS is -0.623.

What Is the Next NeoGenomics Earnings Date?

NeoGenomics will release its next earnings report on 28 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.